text: <unk>  is an N-type calcium channel antagonist that is FDA approved for the {{{indicationType}}} of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include dizziness, nausea, confusional state, nystagmus.
option_0: Ziconotide
option_1: Pasireotide
option_2: Meclizine
option_3: Cilansetron
option_4: Moricizine
option_5: Etelcalcetide
option_6: Dolastetron 
option_7: Granisetron 